Aneuploidy: A report of an ECETOC task force

Mutation Research - Reviews in Mutation Research

Volumn 410, Issue 1, 1998, Pages 3-79

  Aardema, M J ^a   Albertini, S ^a,b   Arni, P ^a   Henderson, L M ^a   Kirsch Volders, M ^a   Mackay, J M ^a   Sarrif, A M ^a   Stringer, D A ^a   Taalman, R D F ^a  

^a European Centre for Ecotoxicology and Toxicology of Chemicals   (Belgium)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACRYLAMIDE; BENOMYL; CADMIUM; CARBENDAZIM; CHLORAL HYDRATE; COLCHICINE; DIAZEPAM; DIETHYLSTILBESTROL; ECONAZOLE; GRISEOFULVIN; HYDROQUINONE; METRIFONATE; NOSCAPINE; ORAL CONTRACEPTIVE AGENT; SPERMICIDAL AGENT; TIABENDAZOLE; VINBLASTINE;

ANEUPLOIDY; BIRTH DEFECT; CHEMICAL MUTAGENESIS; CHROMOSOME ABERRATION; FETUS WASTAGE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CARCINOGENESIS; PREGNANCY COMPLICATION; PRIORITY JOURNAL; REVIEW; TOXICOLOGY;

BACTERIA (MICROORGANISMS); FUNGI; MAMMALIA; RODENTIA;

EID: 0032006333     PISSN: 13835742     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5742(97)00029-X     Document Type: Article

References (242)

1. Adler, I.D., 1993. Synopsis of the in vivo results obtained with the 10 known or suspected aneugens tested in the CEC collaborative study. Mutation Res. 287, 131-137.
2. Afshari, C.A., Kodama, S., Bivins, H.M., Willard, T.B., Fujiki, H., Barrett, J.C., 1993. Induction of neoplastic progression in Syrian hamster embryo cells treated with protein phosphatase inhibitors. Can. Res. 53, 1777-1782.
3. Alberman, E., Creasy, M., Elliott, M., 1976. Maternal factors associated with foetal chromosomal anomalities in spontaneous abortions. Br. J. Obstet. Gynecol. 83, 621-627.
4. Albertini, S., 1993. Aneuploidy assays in routine screening? In: Madle, S., Müller, L. (Eds.), Current Issues in Genetic Toxicology. MMV, Medizin-Verl, Münich, BGA-Schriften 93,1, pp. 64-69.
5. Albertini, S., Chételat, A.-A., Miller, B., Muster, W., Pudjadas, E., Strobel, R., Gocke, E., 1995. Genotoxicity of 17 gyrase-and four mammalian topoisomerase II-poisons in prokaryotic and eukaryotic test systems. Mutagenesis 10, 343-351.
6. Albertini, S., Kirsch-Volders, M., 1997. Summary and conclusions on the MNT in vitro and implication on testing strategies. Mutation Res., 392, 183-185.
7. Aldaz, C., Conti, C., Yuspa, S., Slaga, T., 1988. Cytogenetic profile of mouse skin tumors induced by the viral Harvey-ras gene. Carcinogenesis 9, 1503-1505.
8. Aldaz, C.M., Tronon, D., Larcher, F., Slaga, T.J., Conti, C.J., 1989. Sequential trisomization of chromosomes 6 and 7 in mouse skin premalignant lesions. Mol. Carcinogen. 2, 22-26.
9. Allen, J.W., Lang, J.C., Callano, A.V., Preston, R.J., 1986. Review of literature on chemical-induced aneuploidy in mammalian male germ cells. Mutation Res. 167, 123-137.
10. Anderson, L.C., Letho, V.P., Stenmen, S., Bradley, R.A., Virtanen, I., 1981. Diazepam induces mitotic arrest at prometaphase by inhibiting centriol separation. Nature 291, 247-248.
11. Arni, P., Hertner, Ph., Deparade, E., 1995. Do 'pure' aneugens exist? Investigations in vitro with colcemid, colchicine and vincristine. Intl. Conf. on Chromosome Segregation and Aneuploidy. Sorrento, Italy.
12. Ashby, J.A., 1986. The prospect for a simplified and internationally harmonised approach to the detection of possible human carcinogens and mutagens. Mutagenesis 1, 3-26.
13. Athwal, R.S., Sandhu, S.S., 1985. Use of a human X mouse hybrid cell line to detect aneuploidy-induced by environmental chemicals. Mutation Res. 149, 73-81.
14. Auletta, A.E., Dearfield, K.L., Cimino, M.C., 1993. Mutagenicity Test Schemes and Guidelines: US. EPA Office of Pollution and Prevention and Toxics and Office of Pesticide Programs. Environ. Mol. Mutagen. 21, 38-45.
15. Baird, D.D., Wilcox, J.J., 1985. Cigarette smoking associated with conception delay. J. Am. Med. Assoc. 253 (20), 2979-2983.
16. Barrett, J.C., Fletcher, W.F., 1985. Cellular and molecular mechanisms of multi-step carcinogenesis in cell culture models. In: Barrett, J.C. (Ed.), Mechanisms of Environmental Carcinogenesis: Multi-Step Models of Carcinogenesis, vol. 2. CRC Press, Boca Raton, pp. 73-116.
17. Barrett, J.C., Oshimura, M., Tanaka, N., Tsutsui, T., 1985. Role of aneuploidy in early and late stages of neoplastic progression of Syrian hamster cells in culture. In: Dellarco, V.L., Voytek, P.E., Hollaender, A. (Eds.), Aneuploidy, Etiology and Mechanisms, vol. 36. Plenum Press, pp. 523-538.
18. Bianchi, A.B., Aldaz, C.M., Conti, C.J., 1990. Nonrandom duplication of the chromosome bearing a mutated Ha-ras-1 allele in mouse skin tumors. Proc. Natl. Acad. Sci. USA 87, 6902-6906.
19. Bischoff, F., Yim, S.O., Pathak, S., Grant, G., Siciliano, M.J., Giovanella, B.C., Strong, L.C., Tainsky, M.A., 1990. Spontaneous immortalization of normal fibroblasts from patients with Li-Fraumeni cancer syndrome. Cancer Res. 50, 7979-7984.
20. Bonatti, S., Cavalieri, Z., Viaggi, S., Abbondandolo, A., 1992. The analysis of 10 potential spindle poisons for their ability to induce CREST-positive micronuclei in human diploid fibroblasts. Mutagenesis 7, 111-114.
21. Bond, D.J., Chandley, A.C., 1983. Aneuploidy, Oxford. Monographs on Medical Genetics, No. 11, Oxford University Press, Oxford, UK.
22. Boué, A., Boué, J., Gropp, A., 1985. Cytogenetics of pregnancy wastage. In: Harris, H., Hirschhorn, K. (Eds.), Advance in Human Genetics, vol. 14. Plenum, New York, pp. 1-57.
23. Boveri, T., 1914. Zur Frage der Entstehlund maligner Tumoren. Jena, Gustaf Fisher.
24. Bracken, M.B., Vita, K., 1983. Frequency of non-hormonal contraception around conception and association with congenital malformations in offspring. Am. J. Epidemiol. 117, 281-291.
25. Bryan, J., 1972. Definition of three classes of binding sites in isolated microtubule crystals. Biochemistry 11, 2611-2616.
26. Buchmann, A., Rggerei, B., Klein-Szanto, A.J.P., Balmain, A., 1991. Progression of squamous carcinoma cells to spindle carcinomas of mouse skin is associated with an imbalance of h-ras alleles on chromosome 7. Cancer Res. 51, 4097-4101.
27. Burns, P.A., Kemp, C.J., Cannon, J.V., Lane, D.P., Bremmer, R., Balmain, A., 1991. Loss of heterozygosity and mutational alterations of the p53 gene in skin tumours of interspecific hybrid mice. Oncogene 6, 2363-2369.
28. Butcher, R.L., Page, R.D., 1981. Role of aging in the cessation of reproduction. In: Schwartz, N.B., Hunzicker-Dunn, M. (Eds.), Dynamics at Ovarian Function. Raven Press, New York, pp. 253-271.
29. Caligo, M.A., Rainaldi, G., 1987. Origin of araC-induced endoreduplicated cells. Mutation Res. 177, 261-265.
30. Canada, 1986. Health and Welfare Canada and Environment Canada. Guidelines on the use of mutagenicity tests in the Toxicological Evaluation of Chemicals. A Report of the DNH and W/DOE Environmental Contaninents Advisory Committee on Mutagenesis. Ottawa, Canada.
31. Canada, 1988. Hazardous Products Act, Controlled Products Regulation. Canada Gazette, Part II, 122, p. 551.
32. Canada, 1991. Genotoxicity assays recommended in the Health Protection Branch. Genotoxicity committee report. Conduct and reporting for effective evaluation. Final draft issued by National Health adn Welfare, Canada, May, 1991.
33. Canada, 1993. The assessment of mutagenicity. Health Protection Branch Mutagenicity Guidelines, Published by National Health and Welfare, Canada, June 1992. Environ. Mol. Mutagen., 21, 15-37.
34. Carder, P.J., Wyllie, A.H., Purdie, C.A., Morris, R.G., White, S., Piris, J., Bird, C.C., 1993. Stabilised p53 facilitates aneuploid clonal divergence in colorectal carcinoma. Oncogene 8, 1397-1401.
35. Carder, P.J., Cripps, K.J., Morris, R., Collins, S., White, S., Bird, C.C., Wyllie, A.H., 1995. Mutation of the p53 gene precedes aneuploid clonal divergence in colorectal cancer. Br. J. Cancer 71, 215-218.
36. Castelain, Ph., Deleener, A., Kirsch-Volders, M., Barbason, H., 1989. Cell population kinetics and ploidy rate of early focal lesions during hepatocarcinogenesis on the rat. Br. J. Cancer 60, 827-833.
37. Cavenee, W.K., Scrable, H.J., James, C.D., 1991. Molecular genetics of human cancer predisposition and progression. Mutation Res. 247, 199-202.
38. Cimino, M.C., Tice, R.R., Lang, J.C., 1986. Aneuploidy in mammalian somatic cells in vivo. Mutation Res. 167, 107-122.
39. Cohen, M.M., Levy, M., Eliakim, M., 1977. A cytogenic evaluation of long-term colchicine therapy in the treatment of Familial Mediterranean Fever (FMF). Am. J. Med. Sci. 274, 147-152.
40. Conti, C.J., Aldaz, C.M., O'Conell, J., Klein-Szanto, J.P., Slaga, T.J., 1986. Aneuploidy, an early event in mouse skin tumor development. Carcinogenesis 7, 1845-1848.
41. Coonen, E., Pieters, M.H.E.C., Dumonlin, J.C.M., Meyer, H., Evers, J.L.H., Ramaekers, F.C.S., Geraedts, J.P.M., 1991. Non-isotopic in situ hybridization as a method for non-disjunction studies in human spermatozoas. Mol. Reprod. Dev. 28, 18-22.
42. Cordero, J.F., Layde, P.M., 1983. Vaginal spermicides, chromosomal abnormalities and limb reduction defects. Fam. Plan. Perspect. 15, 16-18.
43. Cox, D.M., Puck, T.T., 1969. Chromosomal nondisjunction: the action of Colcemid on Chinese hamster cells in vitro. Cytogenetics 8, 158-169.
44. Crane, I.J., Patel, V., Scully, C., Prime, S.S., 1989. Development of aneuploidy in experimental oral carcinogenesis. Carcinogenesis 10, 2375-2377.
45. Creasy, M.R., Cralla, J.A., Alberman, E.D., 1976. A cytogenetic study of human spontaneous abortion using banding techniques. Hum. Genet. 31, 177-196.
46. Cross, P.K., Hook, E.B., 1984. Down syndrome and maternal smoking: a negative association. Am. J. Hum. Genet. 36, 905.
47. Czeizel, A.E., 1989. Hungarian surveillance of germinal mutations. Hum. Genet. 82, 359-366.
48. Czeizel, A.C., Elek, C., Grundy, S., Metneki, J., Nemes, E., Reis, A., Sperling, K., Timàr, L., Tusnàdy, G., Virágh, Z., 1993. Environmental trichlorofon and cluster of congenital abnormalities. Lancet 341, 539-542.
49. Danford, N., Parry, J.M., 1986. Induction of sex-chromosome aneuploidy in mice by vincristine sulphate. IRCS Med. Sci. 14, 15-16.
50. Daniel, F.B., DeAngelo, A.B., Stober, J.A., Olson, G.R., Page, N.P., 1992. Hepatocarcinogenicity of chloral hydrate, 2-chloroacetaldehyde and dichloroacteic acid in the male B6C3F1 mouse. Fund. Appl. Toxicol. 19, 159-168.
51. Danielsen, E.H., Brogger, A., Reith, A., 1991. Specific gain of chromosome 19 in preneoplastic mouse liver cells after diethylnitrosamine treatment. Carcinogenesis 12, 1777-1780.
52. Dearfield, K.L., Auletta, A.E., Cimino, M.C., Moore, M.M., 1991. Considerations in the U.S. Environmental Protection Agency's testing approach for mutagenicity. Mutation Res. 258, 259-283.
53. De Brabander, M.R., Vandes, V., Aerts, F., Gennes, S., Hoebeke, J., 1976. A new culture model facilitating rapid quantitative testing of mitotic spindle inhibition in mammalian cells. J. Natl. Cancer Inst. 56, 357-373.
54. De Carli, L., Larizza, L., 1988. Griseofulvin. Mutation Res. 195, 91-126.
55. De Flora, S., Bennicelli, C., Bagnasco, M., 1994. Genotoxicity of mercury compounds: a review. Mutation Res. 317, 57-79.
56. Deleener, A., Castelain, Ph., Préat, V., de Gerlache, J., Alexandre, H., Kirsch-Volders, M., 1987. Changes in nucleolar transcriptional activity and nuclear DNA content during the first steps of rat hepatocarcinogenesis. Carcinogenesis 8, 195-201.
57. Dellarco, V.L., Mavournin, K.H., Tice, R.R., 1985a. Aneuploidy and health risk assessment: current status and future directions. Environ. Mutagen. 7, 405-424.
58. Dellarco, V.L., Mavournin, K.H., Waters, M.D., 1985b. Special Committee Report, part I: An evaluation of current testing approaches for the detection of chemically induced aneuploidy. In: Dellarco, V.L., Voytek, P.E., Hollaender, A. (Eds.), Aneuploidy: Etiology and Mechanisms, Basic Life Sciences, vol. 36. pp. 445-454.
59. Dellarco, V.L., Mavournin, K.H., Waters, M.D., 1986. Aneuploidy Data Review Committee: summary compilation of chemical data base and evaluation of test methodology. Mutation Res. 167, 149-169.
60. Dellarco, V.L., Jacobson-Kram, D., 1988. US-EPA Guidelines for Mutagenicity Risk Assessment and some Comments on Aneuploidy. In: Vig, B.K., Sandberg, A.A. (Eds.), Aneuploidy Part B: Induction and Test Systems. Alan Liss, New York, pp. 7-16.
61. De Stoppelar, J.M., Lowe, X., Cassel, M., Hoebee, B., Bishop, J., Wyrobeck, A.J., 1995. Strain comparison of aneuploidy in rat epididymal sperm detected by FISH using two novel chromosome specific DNA probes. In: Chromosome Segregation and Aneuploidy: An International Conference, Italy, p. 108.
62. De Wals, P., Dolk, H., 1990. Effects of the Chernobyl radiological contamination on human reproduction in western Europe. Prog. Clin. Biol. Res. 340, 339-346.
63. Dische, M.R., Gardner, H.A., 1978. Mixed teratoid tumours of the liver and the neck in trisomy 13. Am. J. Clin. Pathol. 69, 631-637.
64. Doheny, K.F., Puziss, J., Spencer, F., Hieter, P., 1993. Genetic approaches for identifying components in Saccharomyces cerevisae. In: Vig, B.K. (Ed.), NATO ASI Series, H. 72. Springer-Verlag, Berlin, pp. 93-110.
65. Eastmond, D.A., Pinkel, D., 1990. Detection of aneuploidy and aneuploidy-inducing agents in human lymphocytes using fluorescent in situ hybridization with chromosome-specific DNA probes. Mutation Res. 234, 303-318.
66. Eastmond, D.A., Tucker, J.D., 1989a. Identification of aneuploidy-inducing agents using cytokinesis-block human lymphocytes and an antikinetochore antibody. Environ. Mol. Mutagen. 13, 34-43.
67. Eastmond, D.A., Tucker, J.D., 1989b. Kinetochore localization in micronucleated cytokinesis-blocked Chinese hamster ovary cells: a new and rapid assay for identifying aneuploidy-inducing agents. Mutation Res. 224, 517-525.
68. ECETOC, 1997. Aneuploidy. Monograph No. 27.
69. EEC, 1993. Risk assessment of notified new substances technical guidance document. Technical guidance documents in support of the risk assessment directive (93/67/EEC) for substances notified in accordance with the requirements of council directive 67/548/EEC.
70. Eiben, B., Bartels, I., Bähr-Prosch, S., Borgmann, S., Gatz, G., Gellert, G., Goebel, R., Hammans, W., Heutemann, M., Osmers, R., Rauskolb, R., Hausmann, I., 1990. Cytogenetic analysis of 750 spontaneous abortions with the direct preparation method of chorionic villi and its implications for studying genetic causes of pregnancy wastage. Am. J. Hum. Genet. 47, 656-663.
71. Elhajouji, A., van Hummelen, P., Kirsch-Volders, M., 1995. Indications for a threshold of chemically-induced aneuploidy in vitro in human lymphocytes. Environ. Mol. Mutagen. 26, 292-304.
72. Endo, S., Kodama, S., Newbold, R., McLachlan, J., Barrett, J.C., 1994. Cytogenetic analysis of murine cell lines from diethylstilboestrol-induced uterine endometrial adenocarcinomas. Cancer Genet. Cytogenet. 74, 99-103.
73. Erickson, J.D., Mulinaire, J., McClain, P.W., Fitch, T.G., James, L.M., McClearn, A.B., Adams, M.J. Jr., 1984. Vietnam veteran's risk for fathering babies with birth defects. J. Am. Med. Assoc. 252, 903-912.
74. Fearon, E.R., Vogelstein, B., 1990. A genetic model for colorectal tumorigenesis. Cell 61, 759-767.
75. Finlay, G.J., 1993. Genetics, molecular biology and colorectal cancer. Mutation Res. 290, 3-12.
76. Fujii, T., Mikuriya, H., Sasaki, M., 1991. Chronic oral toxicity and carcinogenicity study of thiabendazole in rats. Food Chem. Toxicol. 29, 771-775.
77. Furukawa, A., Ohucida, A., Wierzba, K., 1989. In vivo mutagenicity on polyploid inducers. Environ. Mutagen. 14 (Suppl. 15), 63-64.
78. Galloway, S.M., Ivett, J.L., 1986. Chemically induced aneuploidy in mammalian cells in culture. Mutation Res. 167, 89-105.
79. Galloway, S.M., Aardema, M.J., Ishidate, M., Ivett, J.L., Kirkland, D.J., Morita, T., Mosesso, P., Sofuni, T., 1994. Report from the working group on in vitro tests for chromosomal aberrations. Mutation Res. 312, 241-261.
80. Gatehouse, D.G., Stemp, G., Pascoe, S., Wilcox, P., Hawker, J., Tweats, D.J., 1991. Investigation into the induction of aneuploidy and polyploidy in mammalian cells by the anti-tussive agent noscapine hydrochloride. Mutagenesis 6, 279-283.
81. Gaulden, M.E., 1992. Maternal age effect: the enigma of Down syndrome and other trisomic conditions. Mutation Res. 296, 69-88.
82. Georgieva, V., Vachkova, R., Tzoneva, M., Kappas, A., 1990. Genotoxic activity of benomyl in different test systems. Environ. Mol. Mutagen. 16, 32-36.
83. Giaretti, W., Pujic, A., Nigro, S., Di Vinci, A., Geido, E., Risio, M., 1995. K-ras G-C and G-T transversions correlate with DNA aneuploidy in colorectal carcinomas. Gastroenterology 108, 1040-1047.
84. Gibson, D.P., Aardema, M.J., Kerckaert, G.A., Brauninger, R., Lebouf, R.A., 1995. Detection of aneuploidy-inducing carcinogens in the Syrian Hamster Embryo (SHE) cell transformation assay. Abstracts of the XXVTH EMS Meeting, Portland. Environ. Mol. Mutagen. 23 (Suppl. 23), 20.
85. Guerrero, I., Pellicer, A., 1987. Mutational activation of oncogenes in animal model systems of carcinogenesis. Mutation Res. 185, 293-308.
86. Gurr, J.-R., Lin, Y.-C., Ho, I.-C., Jan, K.-Y., Lee, T.-C., 1993. Induction of chromatid breaks and tetraploidy in Chinese hamster ovary cells by treatment with sodium arsenite during G2 phase. Mutation Res. 319, 135-142.
87. Haesen, S., Derijcke, T., Deleener, A., Castelain, Ph., Alexandre, H., Préat, V., Kirsch-Volders, M., 1988. The influence of phenobarbital and butylated hydroxytoluene on the ploidy rate in rat hepatocarcinogenesis. Carcinogenesis 9, 1755-1761.
88. Haesen, S., Timmermans, M., Kirsch-Volders, M., 1993. Induction of micronuclei and karyotype aberrations during in vivo mouse skin carcinogenesis. Carcinogenesis 14, 11.
89. Han, T., Ozer, H., Sadamori, N., Gajera, R., Gomez, G., Henderson, E.S., Bloom, M.L., Sandberg, A.A., 1983. Significance of pure trisomy 12 compared to other karyotypes in chronic lympocytic leukemia. In: Crispen, R.G. (Ed.), Cancer: Etiology and Prevention. Elsevier/North-Holland, Amsterdam, pp. 21-27.
90. Harjulehto-Mervaala, T., Salonen, R., Aro, T., Saxèn, L., 1992. The accident at Chernobyl and trisomy 21 in Finland. Mutation Res. 275, 81-86.
91. Harlap, S., Barras, M., 1984. Conception waits in fertile women after stopping oral contraceptives. Int. J. Fertil. 29, 73-80.
92. Harvey, M., Sands, A.T., Weiss, R.S., Hegi, M.E., Wiseman, R.W., Pantazis, P., Giovanella, B.C., Tainsky, M.A., Bradley, A., Donehower, L.A., 1993. In vitro growth characteristics of embryo fibroblasts isolated from p53 deficient mice. Oncogene 8, 2457-2467.
93. Hassold, T., 1986. Chromosome abnormalities in human reproductive wastage. Trends Genet. 2, 105-110.
94. Hassold, T., Abruzzo, M., Adkins, K., Griffen, D., Merrill, M., Millie, E., Saker, D., Shen, J., Zaragoza, M., 1996. Human aneuploidy: incidence, origin and etiology. Environ. Mol. Mutagen. 28, 167-175.
95. Hastie, A.C., 1970. Benlate-induced instability of Aspergillus diploids. Nature 226, 771.
96. Hecht, F., 1988. Solid tumour breakpoint update. Cancer Genet. Cytogenet. 31(1), 129-131.
97. Henderson, L., Jones, E., Brooks, T., Chételat, A., Ciliutti, P., Freemantle, M., Howard, C.A., Mackay, J., Phillips, B., Riley, S., Roberts, C., Wotton, A.K., van de Waart, E.J., 1997. Industrial Genotoxicology Group collaborative trial to investigate cell cycle parameters in human lymphocyte cytogenetics studies. Mutagenesis, 12, 163-167.
98. Herens, C., Alvarez Gonzalez, M.L., Barbason, H., 1992. Cytogenetic changes in hepatocarcinomas from rats treated with chronic exposure to diethylnitrosamine. Cancer Genet. Cytogenet. 60, 45-52.
99. Hoffmann, G.R., Dellarco, V.L., Voytek, P.E., 1986. A review of the symposium on aneuploidy: etiology and mechanisms. Environ. Mutagen. 8, 643-651.
100. Holecek, B.U., Kerler, R., Rabes, H., 1989. Chromosomal analysis of a diethylnitrosamine-induced tumorgenic and a nontumorigenic rat liver cell line. Cancer Res. 49, 3024-3028.
101. Holmes, J.M., Martin, R.H., 1993. Aneuploidy detection in human sperm nuclei using fluorescence in situ hybridization. Hum. Genet. 91, 20-24.
102. Hsu, T.C., Shirley, L.R., Takanari, H., 1983. Cytogenetic assays for mitotic poisons: the diploid Chinese Hamster cell system. Anticancer Res. 3, 155-160.
103. Huggins, G., Vessey, M., Flavel, R., Yeates, D., McPherson, K., 1982. Vaginal spermicides and outcome of pregnancy: findings in a large cohort study. Contraception 25, 219-230.
104. IARC (International Agency for Research on Cancer) 1987. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Suppl. 7, Overall Evaluation of Carcinogenicity: An Updating of IARC Monographs Volumes 1 to 42. IARC, Lyon, France.
105. IARC (International Agency for Research on Cancer) 1993. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Beryllium, Cadmium, Mercury and Exposures in the Glass Manufacturing Industry, Vol. 58. IARC, Lyon, France.
106. IARC (International Agency for Research on Cancer) 1996. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Some Pharmaceutical Drugs, Diazepam, Vol. 66. IARC, Lyon, France, p. 19.
107. ICH, 1995. International Committee on Harmonisation of Technical Requirements for the Registration of Pharmaceuticals for Human Use. Step 4. Final Draft, July 18, 1995. Genotoxicity: Guidance on Specific Aspects of Regulatory Genotoxicity Tests for Pharmaceuticals.
108. ICPEMC, 1986. International Commission for the Protection against Environmental Mutagens and Carcinogens. Meeting Report No 3. Is the Incidence of Down Syndrome Increasing?. Mutation Res. 175, 263-266.
109. IPCS, 1993a. International Programme on Chemical Safety Environmental Health Criteria, 148, Benomyl, World Health Organization, Geneva.
110. IPCS, 1993b. International Programme on Chemical Safety Environmental Health Criteria, 149, Carbendazim. World Health Organization, Geneva.
111. IPCS, 1994. International Programme on Chemical Safety Environmental Health Criteria, 157, Hydroquinone. World Health Organization, Geneva.
112. IPCS, 1995. International Programme on Chemical Safety Environmental Health Criteria, 165, Inorganic Lead Compounds. World Health Organization, Geneva.
113. Ireland, C.M., Gull, K., Gutteridge, W.E., Pogson, C.I., 1979. The interaction of benzimidazole carbamates with mammalian microtubule protein. Biochem. Pharmacol. 28, 2680-2682.
114. Ishidate, M., 1988a. Revised Edition Data Book of Chromosomal Aberration Test In Vitro, Elsevier, Amsterdam.
115. Ishidate, M., 1988b. A proposed battery of tests for the initial evaluation of the mutagenic potential of medicinal and industrial chemicals. Mutation Res. 205, 397-407.
116. Ishidate, M., Harnois, M.C., Sofuni, T., 1988a. A comparative analysis of data on the clastogenicity of 951 chemical substances tested in mammalian cell cultures. Mutation Res. 195, 151-213.
117. Ishidate, M., Harnois, M.C., Sofuni, T., 1988b. A proposed battery of tests for the initial evaluation of the mutagenic potential of medicinal and industrial chemicals. Mutation Res. 205, 397-407.
118. Isikara, T., Sasaki, M., Oskimura, M., Kamada, N., Yamada, K., Okada, M., Sakurai, M., Sugiyama, T., Shirarshki, Y., Kohno, S., 1983. A summary of cytogenetic studies on 534 cases of chronic myelocytic leukemia in Japan. Cancer Genet. Cytogenet. 1, 81-92.
119. J-MHW (Japan, Ministry of Health and Welfare), 1990. Guidelines for Toxicity Studies of Drugs. Notification No. 24 of the Pharmaceutical Affairs Bureau, Ministry of Health and Welfare, 1989, Published by Yakuji Nippo Ltd., January 1991.
120. Jeppesen, P., Mitchell, A., Kipling, D., Nicol, L. 1993. Centromere organization in man and mouse. In: Vig, B.K. (Ed.), NATO ASI Series H. 72, Springer-Verlag, Berlin, pp. 63-74.
121. Jick, H., Walker, A.M., Rothman, K.J., Hunter, J.R., Holmes, L.B., Watkins, R.N., D'Ewart, D.C., Danford, A., Madsent, S., 1981. Vaginal spermicides and congenital disorders. J. Am. Med. Assoc. 245, 1329-1332.
122. Kajii, T., Ferrier, A., Niikawa, N., Takahara, H., Ohama, K., Avirachan, S., 1980. Anatomic and chromosomal anomalies in 639 spontaneous abortuses. Hum. Genet. 55, 87-89.
123. Källen, B., 1988. Pregnancy outcome in Sweden after Chernobyl-study with central health registries. National Board of Health and Welfare of Sweden, Stockholm 1-47 (Report No. 33621-348/88).
124. Karayalcin, C., Shankse, A., Honigman, R., 1981. Wilm's tumour in a 13-year old girl with trisomy 18. Am. J. Dis. Child. 135, 53-75.
125. Kaufman, W.K., Levedakou, E.N., Grady, H.L., Faules, R.S., Stein, G.H., 1995. Attenuation of G2 checkpoint function precedes human cell immortalization. Cancer Res. 55, 7-11.
126. Keller, D.A., Heck, H.d'A., 1988. Mechanistic studies on chloral toxicity: relationship to trichloroethylene carcinogenesis. Toxicol. Lett. 42, 183-191.
127. Kilmartin, V., 1981. Purification of yeast tubulin by self-assembly in vitro. Biochemistry 20, 3629-3633.
128. Kirsch-Volders, M., Haesen, S., Deleener, A., Castelain, Ph., Alexandre, H., Préat, V., 1987. Cytogenetic and genetic alterations during hepatocarcinogenesis. In: Roberfroid, M., Préat, V. (Eds.), Biology of Liver Carcinogenesis. Plenum Press, New York, pp. 231-244.
129. Kline, S., Levin, B., Shrout, P., Stein, Z., Susser, M., Warburton, D., 1983. Maternal smoking and trisomy among spontaneous aborted conceptions. Am. J. Hum. Genet. 35, 421-431.
130. Koufus, A., Hansen, M.F., Copeland, N.G., Jenkins, N.A., Lampkin, B.C., Cavanee, W.K., 1985. Loss of heterozygosity in the three embryonal tumours suggests a common pathogenetic mechanism. Nature 316, 330-334.
131. Lafi, A., Parry, E.M., Parry, J.M., 1987. The effects of benzodiazapines upon the fidelity of mitotic cell deivision in cultered Chinese Hamster cells. Mutation Res. 189, 319-332.
132. Lauritsen, J.G., 1975. The significance of oral contraceptives causing chromosome anomalies in spontaneous abortion. Acta Obstet. Gynecol. Scand. 54, 261-264.
133. Li, J., Suzuki, Y., Shimizu, H., Fukumoto, M., Okonogi, H., Nagashima, T., Ishikawa, T., 1993. In vitro micronucleus assay of 30 chemicals in CHL cells. Jikeikai Med. J. 40, 69-83.
134. Livingstone, L.R., White, A., Sprouse, J., Livanos, E., Jacks, T., Tlsty, T.D., 1992. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70, 923-935.
135. Lynch, A.M., Parry, J.M., 1993. The cytochalasin-B micronucleus/kinetochore assay in vitro: studies with 10 aneugens. Mutation Res. 287, 71-86.
136. Mailhes, J.B., Aardema, M.J., 1992. Benomyl-induced aneuploidy in mouse oocytes. Mutagenesis 7, 303-309.
137. Mailhes, J.B., Marchetti, F., 1994. Chemically induced aneuploidy in mammalian oocytes. Mutation Res. 320, 87-111.
138. Mailhes, J.B., Preston, R.J., Lavappa, K.S., 1986. Mammalian in vivo assays for aneuploidy in female germ cells. Mutation Res. 167, 139-148.
139. Marks, F., Furstenberger, G., Gschwendt, M., Rogers, M., Schuring, B., Kaina, B., Bauer, G., 1988. The wound response as a key element for an understanding of multistage carcinogenesis in skin. In: Feo, F., Pani, P., Columbano, A., Garcea, R. (Eds), Chemical Carcinogenesis. Models and Mechanisms. Plenum Press, New York, pp. 217-234.
140. Martin, R.H., Ro, E., Chan, K., 1993. Detection of aneuploidy in human interphase spermatozoa by fluorescence in situ hybridization (FISH). Cytogenet. Cell Genet. 64, 23-26.
141. Martin, R.H., Ko, E., Rademaker, A., 1991. Distribution of aneuploidy in human gametes: comparison between human sperm and oocytes. Am. J. Med. Genet. 39, 321-331.
142. Matsumoto, K., Ohta, T., 1993. Mitosis of rotenon-induced endoreduplication in Chinese hamster cells. Jpn. J. Genet. 68, 185-194.
143. Matsuoka, A., Yamazaki, N., Suzuki, T., Hayashi, M., Sofuni, T., 1993. Evaluation of the micronucleus test using a Chinese hamster cell line as an alternative to the conventional in vitro chromosomal aberration test. Mutation Res. 272, 223-236.
144. Matusi, S.-I., Weinfeld, H., Sandberf, A.A., 1971. Dependence of chromosome pulverization in virus-fused cells on events in the G2 period. J. Natl. Cancer Inst. 47, 401-411.
145. McCann, H., Choi, E., Yamasaki, E.E., Ames, B.N., 1975. Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals. Proc. Natl. Acad. Sci. USA 72, 5135-5139.
146. Mehes, K., Bajnoczky, K., 1990. Clinically recognizable chromosomal abnormalities in newborn infants. Am. J. Med. Genet. 37, 296.
147. Metzler, P.S., 1994. MDM2 and p53: a question of balance. JNCI 86, 1265-1266.
148. Migliore, L., Barale, R., Belluomini, D., Gognetti, A.G., Loprieno, N., 1987. Cytogenetic damage in human lymphocytes by adriamycin and vincristine: a comparison between micronucleus and chromosomal aberration assays. Toxicol. In vitro 1, 247-254.
149. Miller, B.M., 1996. Experiences with the in vitro micronucleus rest (MNT) as a tool for the detection of chromosome aberrations in routine screening. Environ. Mol. Mutagen. 27 (suppl 27), 28.
150. Miller, B.M., Madle, S., Albertini, S., 1994. Can a 'relatively simple' screening procedure for the detection of chemicals with aneugenic potential be recommended at the moment?. Mutation Res. 304, 303-307.
151. Miller, B.M., Albertini, S., Locher, F., Thybaud, V., Lorge, E., 1997. Comparative evaluation of the in vitro micronucleus test and the in vivo chromosome aberration test; industrial experience. Mutation Res., 392, 45-59.
152. Mills, J.L., Harley, E.E., Reed, G.F., Berendes, H.W., 1982. Are spermicides teratogenic?. J. Am. Med. Assoc. 248, 2148-2151.
153. Mitchell, I. D.E.G., Carlton, J.B., Chan, M.Y., Robinson, A., Sunderland, J., 1991. Noscapine-induced polyploidy in vitro. Mutagenesis 6, 479-486.
154. Mitchell, I. DeG., Lambert, R., Burden, M., Sunderland, J., Porter, R.L., Carlton, J.B., 1995. Is polyploidy an important genotoxic lesion?. Mutagenesis 10, 79-83.
155. Mitelman, F., Levan, G., 1981. Clustering of aberrations on specific chromosomes in human neoplasms IV. A survey of 1871 cases. Hereditas 95, 79-139.
156. Mitelman, F., Nilson, P.O., Brandt, L., Alimena, G., Gastaldi, R., Dallapiccola, B., 1981. Chromosome pattern, occupation and clinical features in patients with acute nonlymphocytic leukemia. Cancer Genet. Cytogenet. 4, 197-214.
157. Morita, M., Minowada, J., Sandberg, A.A., 1981. Chromosomes and causation of human cancer and leukemia XLV. Chromosome patterns in stimulated lymphocytes of chronic lymphocytic leukemia. Cancer Genet. Cytogenet. 3, 293-306.
158. Natarajan, A.T., Vyas, R.C., Wiegant, J., Curado, M.P., 1991. A cytogenetic follow-up study on the victims of a radiation accident in Gioania (Brazil). Mutation Res. 287, 47-56.
159. Natarajan, A.T., Duivenvoorden, W.C.M., Meijers, M., Zwanenburg, T.S.B., 1993. Induction of mitotic aneuploidy using Chinese hamster primary embryonic cells. Test results of 10 chemicals. Mutation Res. 287, 47-56.
160. Natarajan, A.T., Balajee, A.S., Boei, J.J.W.A., Chatterjee, S., Darroudi, F., Grigorova, M., Noditi, M., Oh, H.J., Slijepcevic, P., Vermeulen, S., 1994. Recent developments in the assessment of chromosomal damage. Int. J. Radiat. Biol. 66, 615-623.
161. OECD (Organisation for Economic Cooperation and Development), 1996a. Environmental Directorate. Guidelines for the Testing of Chemicals. Guideline 475, Mammalian Bone Marrow Chromosome Aberration Test.
162. OECD (Organisation for Economic Cooperation and Development) 1996b. Environmental Directorate. Guidelines for the Testing of Chemicals. Guideline 473, In Vitro Mammalian Chromosome Aberration Test.
163. OECD (Organisation for Economic Cooperation and Development) 1996c. Environmental Directorate. Guidelines for the Testing of Chemicals. Guideline 474, Mammalian Erythrocyte Micronucleus Test.
164. Olshan, A.F., Baird, P.A., Teschke, K., 1989. Paternal Occupational exposures and the risk of Down syndrome. Am. J. Hum. Genet. 44, 646-651.
165. Oshimura, M., Barrett, J.C., 1986. Chemically-induced aneuploidy in mammalian cells: mechanisms of biological significance in cancer. Environ. Mol. Mutagen. 8, 129-159.
166. Oshimura, M., Hesterberg, T.W., Barrett, J.C., 1986. An early, nonrandom karyotypic change in immortal Syrian hamster cell lines transformed by asbestos: trisomy of chromosome 11. Cancer Genet. Cytogen. 22, 225-237.
167. Oshimura, M., Freeman, A., Sandberg, A.A., 1977. Chromosome and causation of human cancer and leukemia XXVI. Banding studies in acute lymphoblastic leukemia (ALL). Cancer 40, 1161-1171.
168. Ozawa, N., Oshimura, M., McLachlan, J., Barrett, J.C., 1989. Nonrandom karyotypic changes in immortal and tumorigenic Syrian hamster cells induced by diethylstilbestrol. Can. J. Genet. Cytogenet. 38, 271-282.
169. Pacchierotti, F., 1988. Chemically induced aneuploidy in germ cells of mouse. In: Vig, B.K., Sandberg, A.A. (Eds.), Aneuploidy, Part B: Induction and Testing Systems. Alan R. Liss, New York, pp. 123-139.
170. Parry, J.M., Parry, E.M., 1989. Induced chromosome aneuploidy: its role in the genetic assessment of genetic toxicology of environmental chemicals. In: Jolies, G., Cordier, A.(Eds.), Trends in Genetic Assessment. Academic Press, London.
171. Parry, J.M., Sors, A., 1993. The detection and assessment of the aneugenic potential of environmental chemicals: the European Community Aneuploidy Project. Mutation Res. 287, 3-15.
172. Parry, J.M., Parry, E.M., Ellard, S., Warr, T., O'Donovan, J., Lafi, A., 1993. The detection, definition and regulation of aneugenic chemicals. In: Vig, B.K. (Ed.), Chromosome Segregation and Aneuploidy, NATO ASI series, H. 72, Springer-Verlag, Berlin, pp. 391-414.
173. Parry, E.M., Henderson, L., Mackay, J.M., 1995a. Procedures for the detection of chemically induced aneuploidy: recommendations of a UK Environmental Mutagen Society working group. Mutagenesis 10, 1-14.
174. Parry, J.M., Fielder, R.J., McDonald, A., 1995b. Guidelines for testing chemicals; thresholds for aneuploidy-inducing chemicals. Mutation Res. 9, 503-504.
175. Pathak, S., McGill, M., Hsu, T.C., 1975. Actinomycin D effects on mitosis and chromosomes: sticky chromatids and localized lesions. Chromosoma 50, 79-88.
176. Physicians Desk Reference, 1993. PLEASE COMPLETE.
177. Physicians Desk Reference, 1996. PLEASE COMPLETE.
178. Polednak, A.P., Janerich, D.T., 1983. Uses of available record systems in epidemiological studies of reproductive toxicology. Am. J. Ind. Med. 4, 329-348.
179. Polednak, A.P., Janerich, D.T., Glebatis, D.M., 1982. Birth weight and birth defects in relation to maternal spermicide use. Teratology 26, 7-38.
180. Porter, I.M., Paul, B., 1974. Chromosomal anomalies and malignancy. Birth Defects 10, 54-59.
181. Porter, R., Parry, E.M., Parry, J.M., 1992. Morphological transformation of an established Syrian hamster dermal cell with the anti-tussive agent noscapine. Mutagenesis 7, 205-209.
182. Rainaldi, G., Flori, L., Colella, C.M., Mariani, T., Piras, A., Simi, S., Simili, M., 1987. Analysis by BrUdR-labelling technique of induced aneuploidy in mammalian cells in culture. Mutation Res. 177, 255-260.
183. Ramsey, C.N., Ellis, P.M., Zealley, H., 1991. Down's syndrome in the Lothian region of Scotland - 1978 to 1989. Biomed. Pharmacother. 45, 267-272.
184. Roe, F.J.C., Salaman, M.H., 1955. Further studies on incomplete carcinogenesis: triethylene melamine (T.E.M.) 1,2-benzanthracene and propriolactone, as initiator of skin tumor formation in the mouse. Br. J. Cancer 9, 177-203.
185. Rosenberg, L., Palmer, J.R., Zauber, A.G., Warshauer, M.E., Strom, B.L., Harlap, S., Shapiro, S., 1995. Relation of benzodiazepine use to the risk of selected cancers: breast, large bowel, malignant melanoma, lung, endometrium, ovary, non-Hodgkin's lymphoma, testis, Hodgkin's disease, thyroid and liver. Am. J. Epidemiol. 141, 1153-1160.
186. Ruggeri, B., Caamano, J., Goodrow, T., Dirado, M., Bianchi, A., Trono, D., Conti, C.J., Klein-Szanto, A.P.J., 1991. Alterations of the p53 tumor suppressor gene during mouse skin tumor progression. Cancer Res. 51, 6615-6621.
187. Rumsby, P.C., Barrass, N.C., Phillimore, H.E., Evans, J.G., 1991. Analysis of the Ha-ras oncogene in C3H/He mouse liver tumours derived spontaneously or induced with diethylnitrosamine or phenobarbitone. In: Dellarco, V.L., Voytek, P.E., Hollaender, A. (Eds.), Aneuploidy: Etiology and Mechanisms. Carcinogenesis 12, 2331-2336.
188. Russell, L.B., 1985. Experimental approaches for the detection of chromosomal malsegration occurring in the germline of mammals. Basic life Sci. 36, 377-396.
189. Sandberg, A.A., 1980. The Chromosomes in Human Cancer and Leukemia, Springer Verlag, New York.
190. Sandberg, A.A., Turc-Carel, C., 1987. The cytogenetics of solid tumours. Relation to diagnosis, classification and pathology. Cancer 59, 387-395.
191. Sargent, L., Xu, Y., Sattler, G.L., Meisner, L., Pilot, H.C., 1989. Ploidy and karyotype of hepatoytes isolated from enzyme-altered foci in two different protocols of multistage hepatocarcinogenesis in the rat. Carcinogenesis 10, 387-391.
192. Sargent, L.M., Sattler, G.L., Roloff, B., Xu, Y., Sattler, C.A., Meisner, L., Pilot, H.C., 1992. Ploidy and specific karyotypic changes during promotion wilh phenobarbital, 2,5,2′,5′-tetrachlorobiphenyl, and or 3,4,3′,4′-tetrachlori-biphenyl in rat liver. Cancer Res. 52, 955-962.
193. Satya-Prakash, K.L., Liang, J.C., Hsu, T.C., Johnstone, D.A., 1986. Chromosome aberrations in mouse bone marrow cells following treatment in vivo with vinblastine and colcemid. Environ. Mutagen. 8, 273-282.
194. Sbrana, L., Di Sibio, A., Lomi, A., Scarcelli, V., 1993. C-mitosis and numerical chromosome aberration analyses in human lymphocytes: 10 known or suspected spindle poisons. Mutation Res. 287, 57-70.
195. Schiff, P.B., Fant, J., Horwitz, S.B., 1979. Promotion of microtubule assembly in vitro by taxol. Nature 22, 665-667.
196. Schmahl, D., Osswald, H., 1970. Experimental studies on the carcinogenic effects of cancer chemotherapeutics and immunosuppressives. Drug. Res. 20, 1461-1467.
197. Schwarze, P., Saeter, G., Armstrong, D., Cameron, R., Laconi, E., Sarma, D., Préat, V., Seglen, P., 1991. Diploid growth pattern of hepatocellular tumours induced by various carcinogenic treatments. Carcinogenesis 12, 325-327.
198. SCRIP, 1991. No. 1628, June 26th, p. 26.
199. Serra, A., Neri, G., 1990. Trisomy 21: conference report and 1990 update. Am. J. Med. Genet. Suppl. 7, 11-19.
200. Shapiro, S., Stone, D., Heinonen, O.P., Kaufman, D.W., Rosenberg, L., Mitchell, A.A., Helmrich, S.P., 1982. Birth defects and vaginal spermicides. J. Am. Med. Assoc. 247, 2384.
201. Simpson, V.M., Photopus, G.I., 1976. The relationship of neoplasia of disorders of abnormal sexual differentiation. Birth Defects 12, 15-50.
202. Slaga, T., Fisher, S., Weeks, C., Klein-Szanto, A., Reiners, J., 1982. Studies on the mechanisms involved in multistage carcinogenesis in mouse skin. J. Cell Biochem. 18, 99-119.
203. Sofuni, T., 1993. Japanese guidelines for mutagenicity testing. Environ. Mol. Mutagen. 21, 2-7.
204. Sperling, K., Dörries, A., Plätke, R., Struck, E., Gänge, M., Wegner, R.-D., 1987. Häufung von Trisomie 21 fällen unter den Neugeborenen Berlins. Ann. Univ. Sarav. Med. Suppl. 7, 305-313.
205. Sperling, K., Petz, J., Wegner, R.-D., Schulzke, I., Struck, E., 1991. Frequency of trisomy 21 in Germany before and after the Chernobyl accident. Biomed. Pharmacother. 45, 255-262.
206. Stoll, C., Alembikm, B., Dott, B., Roth, M.-P., 1990. Epidemiology of Down syndrome in 118265 consecutive births. Am. J. Med. Genet. Suppl. 7, 79-83.
207. Strobino, B., Kline, J., Lai, A., Stein, Z., Susser, M., Warburton, D., 1985. Spermicide exposure and spontaneous abortions of known karyotype. In: Dellarco, V.L., Voytek, P.E., Hollaender, A. (Eds), Aneuploidy: Etiology and Mechanisms. Basic Life Sciences, vol. 36.
208. Suzuki, K., Suzuki, F., Watanabe, M., Nikaido, O., 1989. Multi-step nature of x-ray-induced neoplastic transformation in golden hamster embryo cells: expression of transformed phenotypes and stepwise change in karyotypes. Cancer Res. 49, 2134-2140.
209. Suzuki, K., Suzuki, F., Nikaido, O., Watanabe, M., 1991. Suppression of differentiation phenotypes in myogenic cells: association of aneuploidy and altered regulation of c-myc gene expression. Exp. Cell Res. 195, 416-422.
210. Swindel, J.A., Ocjey, C.H., 1983. Cytogenetic changes during the early stages of liver carcinogenesis in Chinese hamster: an in vivo-in vitro comparison. Cancer Gen. Cytogen. 10(1), 23-36.
211. Takanari, H., Izutsu, K., 1983. Studies on endoreduplication. III. Endureduplication induced by mitomycin C in PHA-stimulated tonsillar lymphocyte cultures. Mutation Res. 107, 297-306.
212. Tinwell, H., Ashby, J., 1991. Micronucleus morphology as a means to distinguish aneugens and clastogens in the mouse bone-marrow nucleus assay. Mutagenesis 6, 193-198.
213. Tiveron, C., Hartley-Asp, B., Johansson, C.J., Pacchierotti, F., 1993. Noscapine does not show aneugenic activity in mouse oocytes. Mutagenesis 8, 311-315.
214. Tobey, R.A., Petersen, D.F., Puck, T.T., 1966. Life cycle analysis of mammalian cells. III. The inhibition of division on Chinese hamster cells by puromycin and actinomycin. Biophys. J. 6, 567-581.
215. Tomkiel, J.E., Earnshaw, W.C., 1993. Structure of the mammalian centromere. In: Vig, B.K. (Ed.) NATO ASI series, H. 72, Springer-Verlag, Berlin, pp. 13-29.
216. Tsutsui, T., Suzuki, N., Maizumi, H., Barrett, J.C., 1986. Vincristine sulfate-induced cell transformation, mitotic inhibition and aneuploidy in cultured Syrian hamster embryo cells. Carcinogenesis 7, 131-135.
217. Tsutsui, T., Suzuki, N., Maizumi, H., Barrett, J.C., 1990. Aneuploidy-induction in human fibroblasts: comparison with results in Syrian hamster fibroblasts. Mutation Res. 240, 241-249.
218. US-EPA (U.S. Environmental Protection Agency), 1982. Benomyl and thiophanatemethyl; Determination concluding the rebuttable presumption against registration and availability of position document. Fed. Regis. 47 (203), 46747-46755.
219. US-EPA, 1986. Guidelines for mutagenicity risk assessment (51 FR 34007, September 24, 1986). The Bureau of National affairs, Washington, D.C., 73-79.
220. US-FDA (US Federal Drug Agency) 1993. Toxicological Principles for the Safety Assessment of Direct Food Additives and Color Additives Used in Food 'Redbook II'.
221. US-NTP (US-National Toxicology Program), 1989. Toxicology and Carcinogenesis studies of hydrochlorothiazide (CAS No 58-93-5) in F344/N rats and B6C3F1 mice (feed studies). Technical Report Series No. 357.
222. Van Bao, T., Imreh, E., Czeizel, A.E., 1992. Cytogenetic effects of diazepam in peripheral lymphocytes of self-poisoned persons. Mutation Res. 298, 131-137.
223. Van Goethem, F., Ghahroudi, M.A., Castelain, P., Kirsch-Volders, M., 1993. Frequency and DNA content of micronuclei in rat parenchymal liver cells during experimental hepatocarcinogenesis. Carcinogenesis 14(11), 2397-2406.
224. Van Goethem, J., De Stoppelaar, B., Hoebee, B., Kirsch-Volders, M., 1995. Identification of clastogenic and/or aneugenic events during the preneoplastic stages of experimental rat hepatocarcinogenesis, by fluorescence in situ hybridization. Carcinogenesis, 16(8), 1825-1834.
225. Van Hummelen, P., Nüsse, M., Castelain, P., Kirsch-Volders, M., 1995. Aneugen-induced micronuclei (MN) in human lymphocytes may be discerned using image analysis techniques when cell-cycle stage is taken into account. Environ. Mol. Mutagen. 25, 269-278.
226. Verschaeve, L., Kirsh-Volders, M., Susanne, C., Groetenbriel, C., Haustermans, R., Lecomte, A., Rossels, D., 1976. Genetic damage induced by occupationally low mercury exposure. Environ. Res. 12, 306-316.
227. Verschaeve, L., Tassignon, J.-P., Meferve, M., De Stoop, P., Susanne, C., 1979a. Cytogenetic investigation on leukocytes of workers exposed to metallic mercury. Environ. Mutagen. 1, 259-268.
228. Verschaeve, L., Drieson, M., Kirsh-Volders, M., Hens, L., Susanne, C., 1979b. Chromosome distribution after inorganic lead exposure. Hum. Genet. 49, 147-158.
229. Voytek, P.E., 1985. Introduction: Assessment of Health Risks. In: Dellarco, V.L., Voytek, P.E., Hollaender, A. (Eds.). Aneuploidy, Etiology and Mechanisms, Plenum Press, New York, pp. 1-6.
230. Wald, N., Turner, H., Borges, W., 1970. Down's syndrome and exposure to X-irradiation. Ann. New York Acad. Sci. 171, 454-467.
231. Warburton, D., Stein, Z., Kline, J., Susser, M., 1980. Chromosome abnormalities in spontaneous abortion: data from the New York City study. In: Porter, I.H., Hook, E.B. (Eds.), Human Embryonic and Foetal Death. Academic Press, New York, pp. 261-287.
232. Warr, T.J., Parry, E.M., Parry, J.M., 1993. A comparison of two in vitro mammalian cell cytogenetic assays for the detection of mitotic aneuploidy using 10 known or suspected aneugens. Mutation Res. 287, 29-46.
233. Watanabe, T., 1979. Environmental determinants of birth defects prevalence. Contr. Epid. Biostatist. 1, 91-100.
234. Watanabe, M., Suzuki, K., Kodama, S., 1990. Karyotypic changes with neoplastic conversion in morphologically transformed golden hamster embryo cells induced by x-rays. Can. Res. 50, 760-765.
235. Wertelecki, W., Fraumeni, J.E., Mulvihill, T.J., 1970. Nongonadal neoplasia in Turner's syndrome. Cancer 26, 485-488.
236. Whysner, J., Verna, L., English, J.C., Williams, G.M., 1995. Analysis of studies related to tumorigenicity induced by hydroquinone. Reg. Tox. Pharm. 21, 158-176.
237. Willard, H.F., 1992. Centromeres-primary constrictions are primarily complicated. Hum. Mol. Genet. 1, 667-668.
238. Williams, K.L., 1980. Examination of the chromosomes of Polyshondylium pallidum following metaphase arrest by benzimidazole derivatives and colchicine. J. Gen. Microbiol. 116, 409-417.
239. Wilson, L., Morse, A.N.C., 1978. Characterization of acetyl-3H-labeled vinblastine binding to vinblastine-tubulin crystals. J. MoI. Biol. 121, 255-268.
240. Young, R.S., Hansen, K.L., Shapiro, S.D., Jorgenson, R.J., 1984. A high frequency of structural chromosome abnormalities in a south central Texas cytogenetics laboratory. Am. J. Med. Genet. 19, 347-358.
241. Zelesco, P.A., Barbieri, I., Graves, J.A.M., 1990. Use of a cell hybrid cell system to demonstrate that benomyl induces aneuploidy and polyploidy. Mutation Res. 242, 329-335.
242. Zucker, R.M., Adams, D.J., Blair, K.W., Einstein, K.H., 1991. Polyploidy induction as a consequence of topoisomerase inhibition. A flow cytometric assessment. Biochem. Pharmacol. 42, 2199-2208.